Moneycontrol Pro Ideas For Profit: Ipca Labs expected to see 10% topline growth in FY22

Retrieved on: 2021-06-03 07:52:30

Tags for this article:

Click the tags to see associated articles and topics

Moneycontrol Pro Ideas For Profit: Ipca Labs expected to see 10% topline growth in FY22. View article details on hiswai:

Excerpt

In spite of extraordinary sales of hydroxychloroquine in the last financial year, the company is expecting a 9-10 percent topline growth for FY22.

Article found on: www.cnbctv18.com